The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...
Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved ...
Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.